Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,180 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
Bitcoin exchange reserves have fallen to multi-year lows as spot BTC ETFs and corporate treasury buyers pull BTC off ...
As geopolitical tensions rise, investors reassess defense exposure. This report examines the weapons that changed war...
A single AI infrastructure stock delivered an eye-popping 4,800% gain in 12 months. Here’s what drove that rally, wha...
A new era at the Fed could be starting, sparked by a bold move from a hypothetical chair. This piece breaks down what...
A cofounder is suing after being fired for not returning to the office, claiming the mandate applied to employees but...
A deceptive text claiming an Apple charge can spark a dangerous cash-loss scam against seniors. Learn how the fake ap...
Dive into Hamilton Lane's 2026 outlook with a clear, investor-focused breakdown. We explore revenue drivers, AUM grow...
As rates stay elevated in mid-2026, investors are turning to senior loan ETFs for income. A $500,000 position in seni...
Tech ETFs can power long-term gains, especially with AI-driven growth. If you invested $1,000 years ago in VGT, you’d...
A rising wave of spoof calls impersonating bank staff and law enforcement is draining customer accounts. Authorities ...